Daniel R. Herendeen

824 total citations
10 papers, 702 citations indexed

About

Daniel R. Herendeen is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Daniel R. Herendeen has authored 10 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Daniel R. Herendeen's work include DNA Repair Mechanisms (4 papers), Bacterial Genetics and Biotechnology (4 papers) and Immunotherapy and Immune Responses (4 papers). Daniel R. Herendeen is often cited by papers focused on DNA Repair Mechanisms (4 papers), Bacterial Genetics and Biotechnology (4 papers) and Immunotherapy and Immune Responses (4 papers). Daniel R. Herendeen collaborates with scholars based in United States, Mexico and South Korea. Daniel R. Herendeen's co-authors include E. Peter Geiduschek, George A. Kassavetis, Patrick Concannon, Antony M. Carr, Jocyndra Wright, Kathleen S. Keegan, Nicola J. Bentley, Merl F. Hoekstra, Thomas J. Kelly and Joseph R. Nevins and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Daniel R. Herendeen

9 papers receiving 694 citations

Peers

Daniel R. Herendeen
Victoria Marsh United Kingdom
Alexander Munishkin United States
Angel E. Dago United States
Alexandre Regamey Switzerland
K. Zerfass Germany
Pierangela Sabbattini United Kingdom
Christian J. Nievera United States
Victoria Marsh United Kingdom
Daniel R. Herendeen
Citations per year, relative to Daniel R. Herendeen Daniel R. Herendeen (= 1×) peers Victoria Marsh

Countries citing papers authored by Daniel R. Herendeen

Since Specialization
Citations

This map shows the geographic impact of Daniel R. Herendeen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Herendeen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Herendeen more than expected).

Fields of papers citing papers by Daniel R. Herendeen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Herendeen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Herendeen. The network helps show where Daniel R. Herendeen may publish in the future.

Co-authorship network of co-authors of Daniel R. Herendeen

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Herendeen. A scholar is included among the top collaborators of Daniel R. Herendeen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Herendeen. Daniel R. Herendeen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cecil, Denise L., Daniel R. Herendeen, Meredith Slota, et al.. (2025). Identification and Validation of Th1-Selective Epitopes Derived from Proteins Overexpressed in Breast Cancer Stem Cells. Vaccines. 13(5). 525–525.
2.
Cecil, Denise L., Meredith Slota, Megan M. O’Meara, et al.. (2016). Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo. Clinical Cancer Research. 23(13). 3396–3404. 29 indexed citations
3.
Herendeen, Daniel R., et al.. (2016). Th1 epitopes as potential biomarkers for ipilimumab treatment. Annals of Oncology. 27. vi17–vi17. 1 indexed citations
4.
Disis, Mary L., Ekram Gad, Daniel R. Herendeen, et al.. (2013). A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease. Cancer Prevention Research. 6(12). 1273–1282. 59 indexed citations
5.
Wright, Jocyndra, Kathleen S. Keegan, Daniel R. Herendeen, et al.. (1998). Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. Proceedings of the National Academy of Sciences. 95(13). 7445–7450. 185 indexed citations
6.
Herendeen, Daniel R., et al.. (1996). DNA Polymerase III: Running Rings around the Fork. Cell. 84(1). 5–8. 26 indexed citations
7.
Ohtani, Kiyoshi, James DeGregori, Gustavo Leone, et al.. (1996). Expression of the HsOrc1 Gene, a Human ORC1 Homolog, Is Regulated by Cell Proliferation via the E2F Transcription Factor. Molecular and Cellular Biology. 16(12). 6977–6984. 131 indexed citations
8.
Herendeen, Daniel R., George A. Kassavetis, & E. Peter Geiduschek. (1992). A Transcriptional Enhancer Whose Function Imposes a Requirement That Proteins Track Along DNA. Science. 256(5061). 1298–1303. 113 indexed citations
9.
Herendeen, Daniel R., Kelly P. Williams, George A. Kassavetis, & E. Peter Geiduschek. (1990). An RNA Polymerase-Binding Protein That Is Required for Communication Between an Enhancer and a Promoter. Science. 248(4955). 573–578. 61 indexed citations
10.
Herendeen, Daniel R., George A. Kassavetis, J. Marshall Barry, Bruce Alberts, & E. Peter Geiduschek. (1989). Enhancement of Bacteriophage T4 Late Transcription by Components of the T4 DNA Replication Apparatus. Science. 245(4921). 952–958. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026